Prophylactic Donor Lymphocyte Infusion to Prevent Relapse after Allogeneic Stem Cell Transplantation
Journal Title: Journal of Clinical & Medical Case Reports - Year 2014, Vol 1, Issue 1
Abstract
Donor lymphocyte infusion (DLI) has been used to treat disease relapse after stem cell transplantation, but high incidence of graftversus- host disease (GVHD) after traditional DLI, and low response rates with robust relapse in acute leukemia have limited its wide application. Nonetheless, the promising graft versus leukemia effect elicited by DLI makes it a viable option, especially in the state of minimal residual disease after stem cell transplantation. Prophylactic donor lymphocyte infusion has been explored as a more tolerable, less toxic and efficacious option to prevent relapse. This review will summarize the results of the latest prophylactic DLI studies, and discuss our ongoing prophylactic DLI clinical trial after T cell depleted stem cell transplantation in patients with high risk hematologic malignancies.
Authors and Affiliations
Hongtao Liu
Keywords
Related Articles
- EP ID EP207581
- DOI 10.13188/2332-4120.1000002
- Views 175
- Downloads 0
The Havoc of a Giant Spleen
We present a case of a 50-year-old female with previously diagnosed Felty’s syndrome who experienced a number of complications related to massive splenomegaly including cytopenias. The patient required multiple hospitali...
Peripheral Osteoma: Unusual Presentation in the Mandibular Notch
This case report demonstrates an unusual presentation of a large peripheral osteoma affecting the left mandibular notch of a 42-year old female. Only five other cases involving this region have ever been reported in the...
Reye’s like Syndrome in an Adult; a Forgotten Entity
We report a case of 25 years old Caucasian lady who was admitted with history of use of non-steroidal anti-inflammatory drug for a viral like illness, repeated vomiting and hypokalemia. Her endoscopy showed pyloric steno...
Asymptomatic Presentation of Mediastinal Actinomycosis in a Pediatric Patient with AcuteLymphoblastic Leukemia: Case Report and Discussion
We report a nine year old male with Philadelphia positive Precursor B Acute Lymphoblastic Leukemia who was diagnosed with mediastinal actinomycosis following failed central line placement. The patient had a normal chest...
Giant Intraductal Papilloma: A Rare Case
Intraductal papilloma is a benign fibroepithelial tumor of the breast. It constitutes approximately 5% of all breast cancers. Although it can be seen at any age, it is mostly seen in late reproductive age and during peri...